| Filed On | Filing |
|---|---|
| 16 Sep 2026 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
CERTIFICATE OF AMENDMENT TO THE THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF REPLIMUNE GROUP, INC. (Pursuant to Section 242 of the General Corporation Law of the State of Delaware) |
| 24 Aug 2026 |
Form 4: Astley-Sparke Philip, Director
Gave 50,000 shares as a gift |
| 19 Aug 2026 |
Form 4: Hill Emily Luisa, Chief Financial Officer
Sold 9,256 shares ($132K) |
| 14 Aug 2026 | S-3ASR |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | 10-Q |
| 14 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 12 Aug 2026 |
Form 4: Patel Sushil, Director
Sold 39,341 shares ($510K) |
| 12 Aug 2026 |
Form 4: Hill Emily Luisa, Chief Financial Officer
Sold 11,448 shares ($148K) |
| 12 Aug 2026 |
Form 4: Xynos Konstantinos, Chief Medical Officer
Sold 11,447 shares ($148K) |
| 12 Aug 2026 |
Form 4: Schwendenman Andrew, Chief Accounting Officer
Sold 7,632 shares ($99K) |
| 11 Aug 2026 | SCHEDULE 13D/A |
| 11 Aug 2026 |
Form 4: Baker Bros. Advisors Lp, Director and 5 others
Acquired 2,736,340 2026 $0.0001 Prefunded Warrants (Open Market Purchase) ($33M) |
| 11 Aug 2026 |
8-K/A: Other Events
Replimune Group, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [●] or its registered assigns (the “Holder”), is ent... |
| 10 Aug 2026 | SCHEDULE 13G |
| 10 Aug 2026 | 424B5 |
| 10 Aug 2026 | 8-K: Other Events |
| 07 Aug 2026 | SCHEDULE 13G |
| 07 Aug 2026 | 8-K: Other Events |
| 06 Aug 2026 | SCHEDULE 13G/A |
Loading...